articleThe Lancet OncologyMar 10, 2013GREEN OA

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial

European Institute of Oncology · University of Vermont · +14 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,225
total citations
FWCI
43.88
Percentile
100%
References
31
Citations per year

Authors

27

Topics & keywords

Keywords
  • Medicine
  • Sentinel node
  • Axillary Lymph Node Dissection
  • Breast cancer
  • Surgery
  • Axillary lymph nodes
  • Dissection (medical)
  • Clinical endpoint
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.